Clinical Trials Logo

Clinical Trial Summary

Patients with allergic rhinitis frequently present exacerbation of the atopic symptoms during viral infections of the upper respiratory tract. Also, allergic rhinitis makes the mucosa more reactive to infectious agents and potentiates mucus production.

The combination of dexchlorpheniramine, pseudoephedrine and guaifenesin elicits antihistaminic, decongestant and expectorant effects. The study hypothesizes is that this product is superior to dexchlorpheniramine alone in the relief of allergic symptoms and in promoting mucus elimination in atopic patients with viral infections of the upper respiratory tract.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01085721
Study type Interventional
Source Mantecorp Industria Quimica e Farmaceutica Ltd.
Contact Claudia Domingues
Phone +551151885237
Email cdomingues@mantecorp.com
Status Not yet recruiting
Phase Phase 3

See also
  Status Clinical Trial Phase
Completed NCT02013934 - Probiotics in Prevention of Common Cold N/A